RT Journal Article
T1 Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.
A1 Dávila-Fajardo, Cristina Lucía
A1 Díaz-Villamarín, Xando
A1 Antúnez-Rodríguez, Alba
A1 Fernández-Gómez, Ana Estefanía
A1 García-Navas, Paloma
A1 Martínez-González, Luis Javier
A1 Dávila-Fajardo, José Augusto
A1 Barrera, José Cabeza
K1 acenocoumarol
K1 clopidogrel
K1 pharmacogenetics
K1 warfarin
AB There is a special interest in the implementation of pharmacogenetics in clinical practice, although there are some barriers that are preventing this integration. A large part of these pharmacogenetic tests are focused on drugs used in oncology and psychiatry fields and for antiviral drugs. However, the scientific evidence is also high for other drugs used in other medical areas, for example, in cardiology. In this article, we discuss the evidence and guidelines currently available on pharmacogenetics for clopidogrel, warfarin, acenocoumarol, and simvastatin and its implementation in daily clinical practice.
SN 2073-4425
YR 2019
FD 2019-04-01
LK http://hdl.handle.net/10668/13785
UL http://hdl.handle.net/10668/13785
LA en
DS RISalud
RD Apr 11, 2025